Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones

This report presents several potential lead compounds belonging to quinazolinone derivatives for drug discovery against Acanthamoeba infections.PMID:35378058 | DOI:10.1016/j.actatropica.2022.106440

Source: Acta Tropica - April 4, 2022 Category: Infectious Diseases Authors: Usman Ahmed Keat-Yie Ho Samson Eugin Simon Syed Muhammad Saad Seng-Kai Ong Areeba Anwar Kuan Onn Tan Nanthini Sridewi Khalid Mohammed Khan Naveed Ahmed Khan Ayaz Anwar Source Type: research